Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Aïda Amer/Axios

Multiple brands of rapid COVID-19 tests that can be taken at home without a doctor's prescription are finally available over the counter.

Why it matters: Rapid at-home COVID-19 tests put the power of diagnostics in the hands of individual consumers, allowing anyone to surveil themselves regularly for the coronavirus. But getting the most out of them requires a new paradigm around diagnostics — and ultimately, driving down the cost.

What's happening: Abbott's BinaxNow rapid test is available in retail pharmacy chains like Walgreens and CVS, as well as online, at a suggested price of $23.99 for a two-test kit.

  • Quidel's QuickVue rapid test also comes in a pack of two tests and is available online now for about $30.
  • Australia-based Ellume's rapid test will be available in stores and online by the end of May for $38.99.

Context: All of the rapid tests — which can deliver results in as little as 10 to 15 minutes — were developed months ago, but were only recently given emergency use authorization by the FDA.

How it works: Rapid tests work differently than PCR tests, which require visiting a clinic or testing site and giving a nasal swab that is then analyzed by a lab for the genetic material of the SARS-CoV-2 virus.

  • Rapid tests instead look for the presence of a viral antigen — a protein on the surface of the virus that elicits an immune response — that indicates an active infection.

What they're saying: "We see a transition to asymptomatic testing with these diagnostics to get people back to work and school," says Douglas Bryant, CEO of Quidel. "Studies demonstrate that if we can do these tests a couple of times a week, we won't have to go back into lockdown."

That means using the test more for what Bryant calls "serial testing" for regular self-surveillance and less as a one-off to identify a likely infection.

  • In the case of Abbott's BinaxNow, users remove a test card and place six drops of included chemical reagent in a slot on the card.
  • Users then self-collect a nasal sample with an included swab and insert the swab into another slot in the test card, where it is rotated three times to ensure it mixes with the chemical reagent.
  • The card is then sealed, and after 15 minutes, results will be ready, with two pink or purple lines indicating a positive result — meaning an active infection — and one line indicating a negative result.

The catch: A big obstacle for rapid antigen testing is cost: At a minimum of $25 per kit, the current generation of rapid tests is still too expensive for most people to test themselves on a regular basis, which is what needs to happen to get the most out of the new diagnostics.

  • Mass rapid at-home testing would likely require a dedicated government program. In England, everyone in the country is being given access to two tests a week as part of the government's $51 billion Test and Trace program.

What to watch: The CDC and NIH recently launched the first public health initiative in the U.S. to test the effectiveness of rapid at-home tests in curbing COVID-19 outbreaks.

The bottom line: Rapid at-home tests put the power of diagnosis and surveillance in the hands of ordinary Americans, but as with the vaccines, it will only work if we use them.

Go deeper

Aug 5, 2021 - Health

S.C. Rep. Norman tests positive for COVID in breakthrough case

Ralph Norman. Photo: Stefani Reynolds/Bloomberg via Getty Images

Republican Rep. Ralph Norman confirmed Thursday that he has tested positive for COVID-19, making him the second member of South Carolina's delegation to contract a breakthrough case.

Why it matters: Norman is one of a number of GOP lawmakers who refused to wear a face mask on the House floor in May and were subsequently fined.

Graham says he urged Trump "to be aggressive" about COVID vaccine

Photo: Stefani Reynolds/Bloomberg via Getty Images

Sen. Lindsey Graham (R-S.C.), who recently tested positive for COVID-19, told AP on Thursday that he's urged former President Trump "to be aggressive and say, 'Take the vaccine'" to increase vaccination rates.

The big picture: Some Republicans have pushed Trump, who was vaccinated in January, to become more vocal in pushing his supporters to get the vaccine.

Updated Aug 6, 2021 - Technology

CNN fires 3 staffers for coming into office unvaccinated

CNN president Jeff Zucker. Photo: J. Countess/Getty Images

CNN president Jeff Zucker told staff Thursday that the network fired three staff members who came to work without getting vaccinated against COVID-19, according to a memo first obtained by the New York Times.

Driving the news: Zucker said in the memo also shared with Axios that CNN had a "zero-tolerance policy" on coronavirus vaccinations and noted that employees showing proof of having had the vaccine may soon become part of the process of entering network buildings.